Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03542578
Other study ID # PRO00029401
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date September 12, 2018
Est. completion date June 30, 2025

Study information

Verified date August 2023
Source Medical College of Wisconsin
Contact Achuthan Sourianarayanane, MD
Phone 4149556850
Email asourianar@mcw.edu
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study will evaluate whether ultrasound performed during outpatient visit is effective in early diagnosis of fatty liver.


Description:

All patients presenting to dedicated hepatology clinic with concern for fatty liver will be evaluated by ultrasound. This will be compared with standard imaging performed for this condition. The data will be compared for effectiveness of outpatient evaluation with dedicated imaging currently practiced


Recruitment information / eligibility

Status Recruiting
Enrollment 500
Est. completion date June 30, 2025
Est. primary completion date June 30, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - all patients presenting to dedicated clinic Exclusion Criteria: - presence of ascites, inability to give consent to have study

Study Design


Related Conditions & MeSH terms


Intervention

Device:
outpatient evaluation of fatty liver
outcome of ultrasound evaluation of liver in clinical outpatient settings

Locations

Country Name City State
United States Froedtert Hospital Milwaukee Wisconsin

Sponsors (1)

Lead Sponsor Collaborator
Medical College of Wisconsin

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Outpatient ultrasound in diagnosis of fatty liver diagnosis Effectiveness of outpatient evaluation by outpatient bedside ultrasound device in diagnosis of fatty liver compared to standard radiological evaluation. Comparing presence and severity of steatosis reported by standard radiological imaging with bed side imaging tool. Bedside evaluation performed after consent and compared with radiological imaging perfomed within 3 months of this bedside evaluation
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04682600 - The Sonic Incytes Liver Incytes System, Evaluation of Liver Fibrosis and Steatosis Versus MRE and MRI PDFF N/A
Completed NCT06443723 - Metabolic Dysfunction Associated Fatty Liver Disease in Long-Term Cholecystectomy Patients N/A
Not yet recruiting NCT05884723 - Preoperative Ketogenic Diet for Reduction of Hepatic Steatosis N/A
Not yet recruiting NCT05790057 - Subclinical Cardiovascular Changes in NAFLD Patient (Predictive Value of Speckle Tracking Echocardiography )
Completed NCT04579874 - Clinical Performance of LIVERFASt Test Compared w/ Liver Biopsy in Patients w/ NAFLD. N/A
Completed NCT05224037 - Comparative Efficacy of Liver Fibrosis and Steatosis Assessment With Fibroscan and iLivTouch N/A
Recruiting NCT06111859 - Effectiveness of Ultrasound in Liver Stiffness and Fat Quantification N/A
Active, not recruiting NCT06103175 - Observational and Prospective Study of Hepatic Steatosis and Related Risk Factors Using Ultrasound and Artificial Intelligence
Recruiting NCT03699228 - China Health Big Data
Completed NCT03342703 - Correlation of Ultrasound Based Measurements of Liver Stiffness and Steatosis With MRI